Alev Bakir

Alev Bakir

Auto-generated profile, based on publicly available information

Alev Bakir

Department of Social Pediatrics, Institute of Child Health, Istanbul University, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2020 in Gut and Liver
Verified
Journal Article
Open access
PDF file
EKEda Kaya
Eda Kaya
ABAlev Bakir
Alev Bakir
HKHaluk Tarik Kani
Haluk Tarik Kani
CDCoskun Ozer Demirtas
Coskun Ozer Demirtas
CKCaglayan Keklikkiran
Caglayan Keklikkiran
Yusuf YilmazYusuf Yilmaz
Yusuf Yilmaz
Eda Kaya, Alev Bakir, Haluk Tarik Kani, Coskun Ozer Demirtas, Caglayan Keklikkiran, and Yusuf Yilmaz. Gut and Liver 1999;0:. https://doi.org/10.5009/gnl19173

20 January 2020 in Hepatology Forum
Verified
Journal Article
Open access
EKEda Kaya
Eda Kaya
ABAlev Bakir
Alev Bakir
FEFatih Eren
Fatih Eren
Yusuf YilmazYusuf Yilmaz
Yusuf Yilmaz
Background and Aim: Noninvasive scores are developed for the estimation of advanced fibrosis, including parameters in addition to transaminases in non-alcoholic fatty liver disease (NAFLD). In this study, we aimed to investigate the diagnostic performances of Fibrosis-4 (FIB-4) and NAFLD Fibrosis Score (NFS) in the estimation of advanced fibrosis comparing patients with normal and elevated transaminases. Material and Methods: We retrospectively analyzed the prospectively collected data of a total of 407 consecutive patients with biopsy-proven NAFLD. FIB-4 scores of 2.67 or 3.25 indicated a low and high risk for advanced fibrosis, respectively. NFS scores of 0.676 were used to assess low and high risk for advanced fibrosis, respectiv. Results: FIB-4 cutoffs of 3.25 were 97% and 98% in patients with elevated transaminases and 99% and 100% in patients with normal transaminases, respectively. Concerning NFS, we found similar results. Conclusion: FIB-4 and NFS showed acceptable diagnostic performance in the exclusion of advanced fibrosis in both populations with normal and elevated transaminases.

28 February 2022 in Journal of Diabetes
Verified
Journal Article
Open access
EDEmre Durcan
Emre Durcan
SOSerbay Ozkan
Serbay Ozkan
HSHalil Ibrahim Saygi
Halil Ibrahim Saygi
MDMevlut Tamer Dincer
Mevlut Tamer Dincer
OKOzge Polat Korkmaz
Ozge Polat Korkmaz
MGMustafa Sait Gönen
Mustafa Sait Gönen
Background: The aim of this study was to investigate the effects of sodium glucose cotransporter 2 inhibitors (SGLT2i) on the glomerulus through the evaluation of podocyturia in patients with diabetic kidney disease (DKD).Methods: The study population was composed of 40 male patients with type 2 diabetes mellitus; 22 of them received SGLT2i (SGLT2i group), and the others who did not were the control. The DKD‐related parameters of patients were monitored before SGLT2i initiation, and then in the third and sixth month of the follow‐up period. Patients' demographic, clinical, laboratory, and follow‐up data were obtained from medical charts. Microalbuminuria was measured in 24‐h urine. The number of podocytes in the urine was determined by immunocytochemical staining of two different markers, namely podocalyxin (podx) and synaptopodin (synpo). Concentrations of urine stromal cell‐derived factor 1a and vascular endothelial growth factor cytokines were quantified with an enzyme‐linked immunosorbent assay kit.Results: At the end of the follow‐up period, decreases in glycosylated hemoglobin, glucose, systolic and diastolic blood pressure, uric acid level, and microalbuminuria, and improvement in body mass index level and weight loss were significant for the SGLT2i group. On the other hand, there was no significant difference in terms of these parameters in the control group. The excretion of synaptopodin‐positive (synpo+) and podocalyxin‐positive (podx+) cells was significantly reduced at the end of the follow‐up period for the SGLT2i group, while there was no significant change for the control.Conclusions: At the end of the follow‐up period, male patients receiving SGLT2i had better DKD‐related parameters and podocyturia levels compared to baseline and the control group. Our data support the notion that SGLT2i might have structural benefits for glomerular health.

29 August 2024 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
ÖAÖykü Özbörü Aşkan
Öykü Özbörü Aşkan
FKFatma Hande Karpuzoğlu
Fatma Hande Karpuzoğlu
AKAlev Bakır Kayı
Alev Bakır Kayı
TÖTülin Ayşe Özden
Tülin Ayşe Özden
GGGülbin Gökçay
Gülbin Gökçay
GKGonca Keskindemirci
Gonca Keskindemirci

5 September 2022 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
CKCebrail Karaca
Cebrail Karaca
MDMevlut Tamer Dincer
Mevlut Tamer Dincer
ŞÖşeyda gül özcan
şeyda gül özcan
BSBetul Sarac
Betul Sarac
SASaffa Ahmadzada
Saffa Ahmadzada
NSNurhan Seyahi
Nurhan Seyahi
Background: Fabry disease (FD) is a rare metabolic disorder, in which a lifelong enzyme replacement therapy (ERT) constitutes the cornerstone of disease-specific therapy. In this study, we examined the effects of the COVID-19 pandemic and lockdown measures on the management of FD patients. Methods: We collected data in three main domains; mood status, adherence to ERT, and COVID-19 infection. We used the Hospital Anxiety and Depression Scale (HADS) to evaluate the mood statuses of FD patients and the Morisky Medication Adherence Scale (MMAS) and the Medication Adherence Report Scale (MARS) to assess patients’ adherence to non-disease specific therapy. We also examined a control group to compare the mood status data. Results: A total of 67 FD patients (males: 47.8%, mean age: 37.0 years) were recruited to the study, of which 58 were receiving ERT. Both the HADS depression and anxiety scores were higher in the control group compared to FD patients. During the first wave of the pandemic, 25 patients reported to have missed an infusion for a mean of 2.3 ± 1.7 doses and half of the patients had adopted a home-based infusion treatment regimen. COVID-19 infection developed in 25 patients, of which one died. The majority of our patients (71.6%) have had at least one shot of the vaccine. Conclusion: We found that FD patients were more resilient to the negative psychological effects of lockdown. Traumatic growth may be an important factor in explaining this finding. Government-supported home therapy programs might be beneficial for FD patients to increase the therapy adherence.

27 October 2023 in Medicine
Verified
Journal Article
Open access
AEARZU BAYGÜL EDEN
ARZU BAYGÜL EDEN
AKAlev Bakir Kayi
Alev Bakir Kayi
MEMustafa Genco Erdem
Mustafa Genco Erdem
Mehmet DemirciMehmet Demirci
Mehmet Demirci
Background: Machine learning (ML) and artificial intelligence (AI) techniques are gaining popularity as effective tools for coronavirus disease of 2019 (COVID-19) research. These strategies can be used in diagnosis, prognosis, therapy, and public health management. Bibliometric analysis quantifies the quality and impact of scholarly publications. ML in COVID-19 research is the focus of this bibliometric analysis. Methods: A comprehensive literature study found ML-based COVID-19 research. Web of Science (WoS) was used for the study. The searches included “machine learning,” “artificial intelligence,” and COVID-19. To find all relevant studies, 2 reviewers searched independently. The network visualization was analyzed using VOSviewer 1.6.19. Results: In the WoS Core, the average citation count was 13.6 ± 41.3. The main research areas were computer science, engineering, and science and technology. According to document count, Tao Huang wrote 14 studies, Fadi Al-Turjman wrote 11, and Imran Ashraf wrote 11. The US, China, and India produced the most studies and citations. The most prolific research institutions were Harvard Medical School, Huazhong University of Science and Technology, and King Abdulaziz University. In contrast, Nankai University, Oxford, and Imperial College London were the most mentioned organizations, reflecting their significant research contributions. First, “Covid-19” appeared 1983 times, followed by “machine learning” and “deep learning.” The US Department of Health and Human Services funded this topic most heavily. Huang Tao, Feng Kaiyan, and Ashraf Imran pioneered bibliographic coupling. Conclusion: This study provides useful insights for academics and clinicians studying COVID-19 using ML. Through bibliometric data analysis, scholars can learn about highly recognized and productive authors and countries, as well as the publications with the most citations and keywords. New data and methodologies from the pandemic are expected to advance ML and AI modeling. It is crucial to recognize that these studies will pioneer this subject.